
Alert: New Earnings Report (3/3/25)-ADMA Biologics Inc (NASDAQ: ADMA).
ADMA Biologics Inc (NASDAQ: ADMA) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.47 versus a loss $-0.08 for the same period a year ago — a decline of -688%. For […]